What starts as a nice get-together among friends turns into the most horrific experience of their lives as they end up being chased by a psychotic individual whom nothing can stop.

Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Airbus announced that, on Jan. 21, 2025, the A320 ATRA (Advanced Technology Research Aircraft) flew for the first time from the German Aerospace Center (DLR) in Braunschweig, Germany, after the ...

Price Action: ATRA stock is down 4.09% at $6.302 at last check Tuesday.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The modified A320 ATRA also carried out high speed taxi tests. Credit: Peter R Foster IDMA/Shutterstock. Airbus has revealed the completion of ‘first flight’ for German Aerospace Center’s (DLR) ...